Lin BioScience, Inc. (TPEX:6696)
Taiwan · Delayed Price · Currency is TWD 220.50
+29.50 (15.45%)
Oct 9, 2025, 2:59 PM CST
Lin BioScience Market Cap
Lin BioScience has a market cap or net worth of 18.24 billion as of October 10, 2025. Its market cap has increased by 148.91% in one year.
Market Cap
18.24B
Enterprise Value
15.55B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
220.50
Market Cap Chart
Since October 8, 2018, Lin BioScience's market cap has increased from 2.92B to 18.24B, an increase of 525.52%. That is a compound annual growth rate of 29.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 18.24B | 68.72% |
| Dec 31, 2024 | 10.81B | 20.85% |
| Dec 29, 2023 | 8.95B | -28.90% |
| Dec 30, 2022 | 12.58B | -1.94% |
| Dec 30, 2021 | 12.83B | 83.66% |
| Dec 31, 2020 | 6.99B | 284.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 237.31B |
| PharmaEssentia | 198.23B |
| Bora Pharmaceuticals Co., LTD. | 80.80B |
| Lotus Pharmaceutical | 72.85B |
| Lumosa Therapeutics | 45.65B |
| Oneness Biotech | 31.42B |
| Polaris Group | 28.12B |
| Center Laboratories | 25.83B |